"Jayanta Choudhury, MD Mandeep Singh, MD Muhammad Sheikh, MD Lisa Moreno, PA-C"

During the past decade, Research Center of Fresno, Inc. conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 21 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 16 clinical trials were completed. i.e. 266.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Research Center of Fresno, Inc." #1 sponsor was "Gilead Sciences" with 3 trials, followed by "Madrigal Pharmaceuticals, Inc." with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Purdue Pharma LP" with 2 trials sponsored and "Teva Branded Pharmaceutical Products R&D, Inc." with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Research Center of Fresno, Inc." #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "Triangle Biostatistics" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Research Center of Fresno, Inc." are "Nonalcoholic Steatohepatitis" (5 trials), "Chronic Pain" (3 trials), "Chronic Idiopathic Constipation" (2 trials), "Low Back Pain" (2 trials) and "Non Alcoholic Steatohepatitis (NASH)" (2 trials). Many other conditions were trialed in "Research Center of Fresno, Inc." in a lesser frequency.

Most popular intervention types in "Research Center of Fresno, Inc." are "Drug" (29 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "SEL" (3 trials), "Hydrocodone ER" (2 trials), "Hydrocodone bitartrate q24h film-coated tablets" (2 trials) and "Placebo to match SEL 18 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Research Center of Fresno, Inc." are 30 trials for "All" genders.

Currently, there are NaN active trials in "Research Center of Fresno, Inc.". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Research Center of Fresno, Inc., undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Research Center of Fresno, Inc., 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".